Perspective Therapeutics (CATX) Deferred Taxes (2023 - 2024)
Perspective Therapeutics (CATX) posted Deferred Taxes of -$2.1 million for Q4 2024, down 126.72% sequentially from $7.8 million in Q4 2023, and down 126.72% YoY from $7.8 million in Q1 2024.
Perspective Therapeutics (CATX) Deferred Taxes (2023 - 2024) Analysis & Trends
Perspective Therapeutics has reported Deferred Taxes for 2 years, with the latest figure at -$2.1 million in Q4 2024.
- Quarterly Deferred Taxes fell 126.72% year-over-year to -$2.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$2.1 million (up 20.9% YoY) and the FY2024 annual result came in at -$2.1 million, up 20.9% from the prior year.
- Deferred Taxes eased to -$2.1 million in Q4 2024 per CATX's latest filing, from $7.8 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $7.8 million in Q4 2023 and troughed at -$10.5 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 107.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 17.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -181.30 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -300,000.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 235.96 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 600,000.00 |
| 10 | Perspective Therapeutics | 389.10 Mn | 389.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.10 Mn |
| Dec 31, 2023 | 7.85 Mn |
| Mar 31, 2023 | -10.50 Mn |